Abstract
Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1038/s41433-023-02397-z
Journal: Eye | Publication Date: Apr 24, 2023 |
Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study
Join us for a 30 min session where you can share your feedback and ask us any queries you have